Drug Search Results
More Filters [+]

Dimepranol

Alternative Names: dimepranol
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bosnia | Bulgaria | Croatia | Germany | Hong Kong | Hungary | Latvia | Morocco | Philippines | Slovakia | United Arab Emirates | United Kingdom | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Ewopharma AG.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dimepranol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Inflammation

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2013-003303-18

P4

Terminated

Inflammation

None

Recent News Events

Date

Type

Title